SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-19-000262
Filing Date
2019-03-08
Accepted
2019-03-08 08:07:18
Documents
2
Period of Report
2019-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k11577002_03082019.htm 8-K 16360
2 ex991to8k11577002_03082019.htm EX-99.1 74174
  Complete submission text file 0001193805-19-000262.txt   92036
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 19667634
SIC: 2834 Pharmaceutical Preparations